Physician

Bryan Johannes Vekovius, M.D.

According to 2025 Medicare claims, Bryan Vekovius, M.D. (NPI: 1285674820) practices ophthalmology in the Shreveport-Bossier City, LA market, with the plurality of this provider's patient population coming from Caddo, LA. This provider's primary affiliated billing organization is BRYAN VEKOVIUS M.D. LLC (NPI: 1700085727; TIN: 943426436) and primary practice location at 71106-7228. Vekovius is affiliated with the Ochsner Accountable Care Network, LLC (ACO ID: A1535) and CHRISTUS Health Quality Care Alliance (ACO ID: A3029), participating under the MSSP model.

Vekovius' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,189 traditional Medicare patients, billed 24,210 HCPCS/CPT codes, and received $680,599 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 4,786 prescription claims across 1,141 beneficiaries totaling $5,064,336 in drug costs, led by Ultomiris (Ravulizumab-Cwvz). DME data shows 213 claims. Open Payments data shows 143 records totaling $10,983. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $174,225 to $5,064,336. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $6,613 and ending at $9,166.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,261	16,031	$719,042
2016	1,175	14,084	$611,019
2017	1,181	16,402	$638,046
2018	1,305	20,305	$781,530
2019	1,297	22,102	$764,511
2020	1,053	20,804	$552,510
2021	1,154	24,572	$668,989
2022	1,191	24,310	$693,874
2023	1,191	22,783	$678,800
2024	1,189	24,210	$680,599

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	650	2,136	$174,225
2016	625	2,075	$194,708
2017	677	2,336	$240,391
2018	771	2,609	$291,571
2019	826	3,142	$347,448
2020	739	3,105	$2,533,745
2021	837	3,469	$696,795
2022	925	3,779	$1,059,146
2023	937	3,964	$3,166,888
2024	1,141	4,786	$5,064,336

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	34	$1,775
2016	40	140	$4,659
2017	53	168	$5,087
2018	58	148	$4,435
2019	55	160	$5,569
2020	22	91	$2,760
2021	29	132	$5,071
2022	29	131	$5,573
2023	27	154	$7,269
2024	38	213	$7,935

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92014	Established patient complete exam of visual system	614	1,013	$82
92012	Established patient problem focused exam of visual system	502	833	$58
92083	Exam of visual field with extended testing	739	1,240	$42
92250	Photography of the retina	934	1,251	$23
92285	Photography of content of eyes	516	627	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ultomiris	Ravulizumab-Cwvz	27	1,267	$1,478,594
Tepezza	Teprotumumab-Trbw	18	378	$1,178,211
Restasis	Cyclosporine	183	10,665	$211,646
Xiidra	Lifitegrast	57	4,350	$95,315
Cyclosporine	Cyclosporine	52	3,172	$33,562

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7030	Full face mask used with positive airway pressure device, each	N	N/R	22	$1,817
A7031	Face mask interface, replacement for full face mask, each	N	N/R	23	$1,495
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	11	29	$1,032
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	23	$881
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	N/R	12	$705

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	143	$10,983	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bryan Johannes Vekovius, M.D.?

Tedicare shows public-source Medicare data for Bryan Johannes Vekovius, M.D. (NPI 1285674820), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bryan Johannes Vekovius, M.D. have ACO affiliation data?

Bryan Johannes Vekovius, M.D. is shown with ACO affiliation data for Ochsner Accountable Care Network, LLC (MSSP, ACO ID A1535) and CHRISTUS Health Quality Care Alliance (MSSP, ACO ID A3029).

What billing organization is linked to Bryan Johannes Vekovius, M.D.?

Bryan Johannes Vekovius, M.D. is linked to BRYAN VEKOVIUS M.D. LLC (billing NPI 1700085727) in the available physician profile data.

Does Bryan Johannes Vekovius, M.D. have Open Payments data?

Bryan Johannes Vekovius, M.D. has 143 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.